0 Commenti
0 condivisioni
716 Views
Cerca
Scopri nuove persone e i loro amici a quattro zampe, e fai nuove amicizie
-
Effettua l'accesso per mettere mi piace, condividere e commentare!
-
Global Oncology Drug Market Insights: Opportunities and ForecastsOncology Drugs Market: Driving Innovation in the Global Fight Against Cancer Cancer continues to be one of the leading causes of death worldwide, placing immense pressure on healthcare systems and driving the need for more effective treatments. As a result, the global oncology drugs market has become one of the fastest-growing segments of the pharmaceutical industry. With...0 Commenti 0 condivisioni 1K Views
-
Global Oncology Drug Market Insights: Opportunities and ForecastsOncology Drugs Market: Driving Innovation in the Global Fight Against Cancer Cancer continues to be one of the leading causes of death worldwide, placing immense pressure on healthcare systems and driving the need for more effective treatments. As a result, the global oncology drugs market has become one of the fastest-growing segments of the pharmaceutical industry. With...0 Commenti 0 condivisioni 1K Views
-
Growing Oncology Drug Development Driving the High Potency Active Pharmaceutical Ingredients MarketModern medicine increasingly relies on powerful therapies that work at extremely small doses. Many breakthrough drugs for cancer, hormonal disorders, and targeted therapies depend on compounds that are highly potent yet precisely controlled. These substances are known as High Potency Active Pharmaceutical Ingredients (HPAPIs). The HP (High Potency) Active Pharmaceutical...0 Commenti 0 condivisioni 1K Views
-
Long-Acting Injectable Oncology Drug Market Segmentation & Forecast, Share, SizeFuture of Executive Summary Long-Acting Injectable Oncology Drug Market Market: Size and Share Dynamics The global long-acting injectable oncology drug market size was valued at USD 7.16 billion in 2025 and is expected to reach USD 17.60 billion by 2033, at a CAGR of 11.90% during the forecast period. A DBMR team of experts and professionals from a...0 Commenti 0 condivisioni 946 Views
-
Long-Acting Injectable Oncology Drug Market Size, Share, Segments and TrendExecutive Summary Long-Acting Injectable Oncology Drug Market Growth Trends and Share Breakdown The global long-acting injectable oncology drug market size was valued at USD 7.16 billion in 2025 and is expected to reach USD 17.60 billion by 2033, at a CAGR of 11.90% during the forecast period. This global Long-Acting Injectable Oncology Drug Market...0 Commenti 0 condivisioni 718 Views
-
Brigatinib API Market Growing at 8.1% CAGR Through 2034 GloballyAccording to a new report from Intel Market Research, the global Brigatinib API market was valued at USD 42.5 million in 2025 and is projected to reach USD 89.7 million by 2034, growing at a robust CAGR of 8.1% during the forecast period (2026–2034). This growth is propelled by the increasing global incidence of non-small cell lung cancer, particularly ALK-positive cases among...0 Commenti 0 condivisioni 1K Views
-
Circular RNA Therapeutics Market Size, Industry Trends, and Growth Forecast to 2033According to the latest report published by Data Bridge Market Research, the Circular RNA Therapeutics Market The global Circular RNA Therapeutics market size was valued at USD 784 Million in 2025 and is expected to reach USD 4188.13 Million by 2033, at a CAGR of 23.30% during the forecast period To impart a supreme quality to this persuasive Circular RNA...0 Commenti 0 condivisioni 62 Views
-
Crizotinib Drugs Market Growing at 6.7% CAGR Through 2034According to a new report from Intel Market Research, the global Crizotinib Drugs market was valued at USD 582.4 million in 2025 and is projected to reach USD 1,043.7 million by 2034, growing at a CAGR of 6.7% during the forecast period (2026–2034). This growth is propelled by the rising global incidence of lung cancer, increasing adoption of molecular diagnostic testing for genetic...0 Commenti 0 condivisioni 1K Views
-
Global Cabozantinib Drug Market Growing at 7.5% CAGR Through 2034According to a new report from Intel Market Research, the global Cabozantinib Drug market was valued at USD 2.12 billion in 2025 and is projected to reach USD 4.01 billion by 2034, growing at a robust CAGR of 7.5% during the forecast period (2026–2034). This growth is propelled by the escalating global burden of cancer, particularly renal and liver cancers, alongside expanding clinical...0 Commenti 0 condivisioni 1K Views
-
Global Multi-target MET TKIs Market Growing at 7.6% CAGR Through 2034According to a new report from Intel Market Research, the global Multi-target MET TKIs market was valued at USD 1.52 billion in 2025 and is projected to reach USD 3.18 billion by 2034, growing at a CAGR of 7.6% during the forecast period (2026–2034). This growth is propelled by the rising global incidence of non-small cell lung cancer and medullary thyroid cancer, precision oncology...0 Commenti 0 condivisioni 1K Views
-
Global Selpercatinib Capsules Market Growing at 7.8% CAGR Through 2034According to a new report from Intel Market Research, the global Selpercatinib Capsules market was valued at USD 420 million in 2025 and is projected to reach USD 820 million by 2034, growing at a CAGR of 7.8% during the forecast period (2026–2034). This growth is propelled by the increasing prevalence of RET-altered cancers, growing adoption of biomarker-driven therapies, and...0 Commenti 0 condivisioni 1K Views
-
High Potency Active Pharmaceutical Ingredients Market to Reach USD 66.38 Billion by 2033, Growing at 9.37% CAGRMarket Overview The global high potency active pharmaceutical ingredients market size was valued at USD 29.64 billion in 2024 and is projected to grow from USD 32.42 billion in 2025 to reach USD 66.38 billion in 2033, growing at a CAGR of 9.37% during the forecast period (2025–2033). The global High Potency Active Pharmaceutical Ingredients market...0 Commenti 0 condivisioni 3K Views
-
TKIs for Breast Cancer Market Growing at 7.3% CAGR Through 2034According to a new report from Intel Market Research, the global TKIs for Breast Cancer market was valued at USD 1.82 billion in 2025 and is projected to reach USD 3.74 billion by 2034, growing at a CAGR of 7.3% during the forecast period (2025–2034). This growth is propelled by the rising global incidence of breast cancer, growing adoption of precision oncology, and increasing regulatory...0 Commenti 0 condivisioni 1K Views
-
United States ADC for Solid Tumors Market Growing at 8.9% CAGR Through 2034The United States Antibody‑Drug Conjugate (ADC) for Solid Tumors market size was valued at approximately USD 0.55 billion in 2025. The market is projected to grow from approximately USD 0.58 billion in 2026 to around USD 1.04 billion by 2034, exhibiting a CAGR of about 8.9% during the forecast period. Antibody‑Drug Conjugates are targeted therapeutics that combine a monoclonal antibody that...0 Commenti 0 condivisioni 70 Views
Pagine in Evidenza
© 2026 Khajiit Nation
Italiano
Italiano
English
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Russian
Romaian
Portuguese (Brazil)
Greek